Christopher is an experienced market access executive with a demonstrated history of leading and building successful teams in established and emerging biopharmaceutical companies. He's strategic and operational leadership of pipeline, inline and launch product pricing, market access, and HEOR across a range of therapeutic areas. Christopher has extensive knowledge of the US and international healthcare systems.